Cargando…
COVID-19 imparted immune manifestation can be combated by NLGP: Lessons from cancer research
SARS-CoV-2 easily infects human monocytes, macrophages and possibly dendritic cells (DCs), causing dysfunctions of these important antigen presenting cells (APCs). Observed DC dysfunctions facilitate improper antigen presentation, which obviously results T cell anergy, exhaustion and apoptosis, thus...
Autores principales: | Bose, Anamika, Baral, Rathindranath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339246/ https://www.ncbi.nlm.nih.gov/pubmed/35921791 http://dx.doi.org/10.1016/j.cyto.2022.155980 |
Ejemplares similares
-
NLGP Attenuates Murine Melanoma and Carcinoma Metastasis by Modulating Cytotoxic CD8(+) T Cells
por: Bhuniya, Avishek, et al.
Publicado: (2020) -
NLGP counterbalances the immunosuppressive effect of tumor-associated mesenchymal stem cells to restore effector T cell functions
por: Ghosh, Tithi, et al.
Publicado: (2019) -
Surface Alterations to Impart Antiviral Properties to Combat COVID-19 Transmission
por: Siddiquie, Reshma Y., et al.
Publicado: (2020) -
Neem Leaf Glycoprotein Prophylaxis Transduces Immune Dependent Stop Signal for Tumor Angiogenic Switch within Tumor Microenvironment
por: Banerjee, Saptak, et al.
Publicado: (2014) -
Neem Leaf Glycoprotein Activates CD8(+) T Cells to Promote Therapeutic Anti-Tumor Immunity Inhibiting the Growth of Mouse Sarcoma
por: Mallick, Atanu, et al.
Publicado: (2013)